In a reverse merger transaction on Sept. 28. Under the terms of the transaction, each share of AppHarvest common stock issued and outstanding will be canceled and converted into the right to receive the number of shares of common stock of Novus equal to the quotient obtained by dividing 50 million by the total number of shares of AppHarvest common stock outstanding, excluding any shares issuable upon the conversion of up to $30 million in aggregate principal amount of AppHarvest Interim Period Convertible Notes.
Related Posts
Health Sciences Acquisitions 2 Merging with Orchestra BioMed in $158M Deal
On a pro forma basis, Orchestra BioMed Holdings is expected to receive a minimum of $180 million in gross proceeds from the merger and Series D financing.
GigCapital3 Files Prelim Proxy on Lightning eMotors Deal
The SPAC inserted a placeholder for an as-yet unannounced date for a shareholder vote in 2021.
Sagaliam Acquisition Inks Deal for Enzolytics Subsidiaries
The SPAC in June amended a non-binding term sheet for the purchase of Enzolytics to $450 million. The initial term sheet called for a purchase price of $250 million.
AirAsia Parent Plans to List Some of its Businesses via Aetherium Acquisition
Capital A Berhad, the parent of AirAsia, also plans to raise more than $1 billion in debt and equity.